These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17257225)

  • 1. Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin.
    Larsen A; Bronstein IB; Dahl O; Wentzel-Larsen T; Kristoffersen EK; Fagerhol MK
    Scand J Immunol; 2007 Feb; 65(2):192-201. PubMed ID: 17257225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis.
    Foell D; Kane D; Bresnihan B; Vogl T; Nacken W; Sorg C; Fitzgerald O; Roth J
    Rheumatology (Oxford); 2003 Nov; 42(11):1383-9. PubMed ID: 12832707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma S100A12 concentrations in peritoneal dialysis patients and subclinical chronic inflammatory disease.
    Uchiyama-Tanaka Y; Mori Y; Kosaki A; Kimura T; Moriishi M; Kawanishi H; Matsubara H
    Ther Apher Dial; 2008 Feb; 12(1):28-32. PubMed ID: 18257809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
    Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS
    Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease.
    Zakiyanov O; Kalousová M; Kříha V; Zima T; Tesař V
    Kidney Blood Press Res; 2011; 34(6):457-64. PubMed ID: 21822023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay validation and biological variation of serum receptor for advanced glycation end-products.
    Brown LF; Fraser CG
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):518-9. PubMed ID: 18753428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and analytic validation of an immunoassay for the quantification of canine S100A12 in serum and fecal samples and its biological variability in serum from healthy dogs.
    Heilmann RM; Lanerie DJ; Ruaux CG; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):200-9. PubMed ID: 22030158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes.
    Kosaki A; Hasegawa T; Kimura T; Iida K; Hitomi J; Matsubara H; Mori Y; Okigaki M; Toyoda N; Masaki H; Inoue-Shibata M; Nishikawa M; Iwasaka T
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5423-8. PubMed ID: 15531492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome.
    Wittkowski H; Sturrock A; van Zoelen MA; Viemann D; van der Poll T; Hoidal JR; Roth J; Foell D
    Crit Care Med; 2007 May; 35(5):1369-75. PubMed ID: 17414728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A12 (EN-RAGE) in monitoring Kawasaki disease.
    Foell D; Ichida F; Vogl T; Yu X; Chen R; Miyawaki T; Sorg C; Roth J
    Lancet; 2003 Apr; 361(9365):1270-2. PubMed ID: 12699958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum.
    Vissers JL; Mersch ME; Rosmalen CF; van Heumen MJ; van Geel WJ; Lamers KJ; Rosmalen FM; Swinkels LM; Thomsen J; Herrmann M
    Clin Chim Acta; 2006 Apr; 366(1-2):336-40. PubMed ID: 16405937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large molecular size EDTA-resistant complexes containing S100A12, ERAC, in serum during inflammatory conditions.
    Fagerhol MK; Larsen A; Brun JG; Hammer HB; Angel K; Kvien TK; Kinne I; Madland TM
    Scand J Clin Lab Invest; 2012 Apr; 72(2):129-36. PubMed ID: 22248048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple structural states of S100A12: A key to its functional diversity.
    Moroz OV; Dodson GG; Wilson KS; Lukanidin E; Bronstein IB
    Microsc Res Tech; 2003 Apr; 60(6):581-92. PubMed ID: 12645006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis.
    Mori Y; Kosaki A; Kishimoto N; Kimura T; Iida K; Fukui M; Nakajima F; Nagahara M; Urakami M; Iwasaka T; Matsubara H
    Am J Nephrol; 2009; 29(1):18-24. PubMed ID: 18663285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of alpha-synuclein concentration in human plasma using ELISA.
    Fjorback AW; Varming K; Jensen PH
    Scand J Clin Lab Invest; 2007; 67(4):431-5. PubMed ID: 17558898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium status of the Australian population: effect of age, gender and cardiovascular disease.
    Lymbury R; Tinggi U; Griffiths L; Rosenfeldt F; Perkins AV
    Biol Trace Elem Res; 2008 Dec; 126 Suppl 1():S1-10. PubMed ID: 18797826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic roles of S100A12 in coronary atherosclerotic plaque formation and rupture.
    Goyette J; Yan WX; Yamen E; Chung YM; Lim SY; Hsu K; Rahimi F; Di Girolamo N; Song C; Jessup W; Kockx M; Bobryshev YV; Freedman SB; Geczy CL
    J Immunol; 2009 Jul; 183(1):593-603. PubMed ID: 19542470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100B in bone marrow aspirates in healthy individuals and malignant melanoma patients.
    Faye RS; Paus E; Maelandsmo GM; Berner A; Høifødt HK; Fodstad Ø; Aamdal S
    Melanoma Res; 2008 Apr; 18(2):134-40. PubMed ID: 18337650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A12 gene expression is increased in peripheral leukocytes in chronic kidney disease stage 4-5 patients with cardiovascular disease.
    Hara M; Ando M; Morito T; Nokiba H; Iwasa Y; Tsuchiya K; Nitta K
    Nephron Clin Pract; 2013; 123(3-4):202-8. PubMed ID: 23921255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.